Sick sinus syndrome induced by interferon and ribavirin therapy in a patient with chronic hepatitis C
Open Access
- 1 December 2013
- journal article
- case report
- Published by Elsevier in Journal of Cardiology Cases
- Vol. 8 (6), 173-175
- https://doi.org/10.1016/j.jccase.2013.08.002
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Direct regulation of membrane type 1 matrix metalloproteinase following myocardial infarction causes changes in survival, cardiac function, and remodelingAmerican Journal of Physiology-Heart and Circulatory Physiology, 2011
- Myocardial Matrix Remodeling and the Matrix Metalloproteinases: Influence on Cardiac Form and FunctionPhysiological Reviews, 2007
- Effects of interferon plus ribavirin treatment on NF-κB, TGF-β1, and metalloproteinase activity in chronic hepatitis CLaboratory Investigation, 2006
- Peginterferon Alfa-2a plus Ribavirin for Chronic Hepatitis C Virus Infection in HIV-Infected PatientsNew England Journal of Medicine, 2004
- Side effects of therapy for chronic hepatitis CGastroenterology, 2003
- Differential Expression of Tissue Inhibitors of Metalloproteinases in the Failing Human HeartCirculation, 1998
- A Case of Chronic Hepatitis C with Sinus Bradycardia during IFN Therapy.The Kurume Medical Journal, 1998
- Adverse Effects of Interferon on the Cardiovascular System in Patients with Chronic Hepatitis C.Japanese Heart Journal, 1996
- Cardiotoxicity of Interferon*Chest, 1991
- Pathology of sinoatrial node. Correlations with electrocardiographic findings in 111 patientsAmerican Heart Journal, 1977